Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodayPrecious Metals
Gold Price TodayNew
Silver Price TodayNew
Platinum Price TodayNewSmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Uniphos Enterprises
Small Cap•IPO 1994
Current Price
₹95.11
0.87 (0.92%)Updated
Today's Range
90
₹95.11
96.97
52 Week Range
52W Low₹87.51
52W High₹168.50
₹95.11
Downside8.68%
Upside77.16%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹799.78 Cr
Market Cap
Total market value of companyP/E Ratio
42.12
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
0.37
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹2.73
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
0.77%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
0.06%
ROCE
Return on Capital Employed. >15% is goodNet Margin
-0.27%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
-57.46%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
254.21%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
93.40%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
-393.00%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
-
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹394.22
Book Value
Net asset value per shareDividend Yield
0.43%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
73.80%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
5 points- •Promoter holding is robust at 73.8%, indicating strong management confidence.
- •Zero debt-to-equity ratio (0.00) provides significant financial stability.
Weaknesses
5 points- •Reported negative quarterly profit after tax of -0.74 Cr.
- •Extremely low ROCE (0.06%) and ROE (0.01%) indicate poor capital returns.
Opportunities
4 points- •Capitalize on broader chemicals industry expansion leveraging existing trading infrastructure.
- •Low P/B (0.38) suggests significant upside if fundamentals improve.
Threats
4 points- •Highly competitive 'Trading - Chemicals' sector poses threat from larger players.
- •Economic slowdown could depress chemical demand, exacerbating weak sales.
Segment-wise Financial Analysis
Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹111.99 | +₹16.88 | +17.75% |
| R3 | ₹105.02 | +₹9.91 | +10.42% |
| R2 | ₹101.00 | +₹5.89 | +6.19% |
| R1 | ₹98.05 | +₹2.94 | +3.09% |
| PIVOT | ₹94.03 | -1.08 | -1.14% |
| CURRENT | ₹95.11 | - | - |
| S1 | ₹77.14 | -₹17.97 | -18.89% |
| S2 | ₹84.11 | -₹11.00 | -11.56% |
| S3 | ₹87.06 | -₹8.05 | -8.47% |
| S4 | ₹91.08 | -₹4.03 | -4.23% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume-85.0% vs avg
0.02L
(02 Apr 2026)Delivery %-4.6% vs avg
67.2%
(02 Apr 2026)Avg Volume (20D)20-day average
0.11L
(04 Mar - 02 Apr)Avg Delivery %Trend ↑
71.9%
(04 Mar - 02 Apr)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Adani Enterprises Ltd
2.90L ₹ Cr
Best Profit Growth
Hindware Home Innovation Ltd
614.00 %
Highest Dividend Yield
Vintage Coffee & Beverages Ltd
0.09 %
Peer Comparison
| Company Name |
|---|
 Adani Enterprises Ltd |
 Arisinfra Solutions Ltd |
 |
 Creative Newtech Ltd |
 Hardwyn India Ltd |
 Hexa Tradex Ltd |
 Hindware Home Innovation Ltd |
 State Trading Corporation of India Ltd |
 Tara Chand Infralogistic Solutions Ltd |
 Vintage Coffee & Beverages Ltd |
About
Uniphos Enterprises Ltd
Uniphos Enterprises Limited (UEL) is an Indian company primarily involved in the trading of chemicals and other products within the domestic market. This forms a core component of its business operations, encompassing the sourcing, distribution, and sale of a diverse range of chemical commodities. The specifics of these chemical products and their applications are not detailed in the provided information, but it's clear that chemical trading represents a significant aspect of UEL's revenue generation.
Beyond its chemical trading activities, UEL also participates in the investment sector. The company engages in investments in both listed (quoted) and unlisted (unquoted) securities. This diversification suggests a strategy aimed at balancing risk and potentially generating additional returns beyond the trading arm of the business. The nature and scale of these investments – whether in stocks, bonds, or other securities – remain unspecified in the provided context.
Established in 1969 and headquartered in Mumbai, India, UEL boasts a relatively long history in the Indian business landscape. This suggests a degree of established market presence and potentially strong relationships within the chemical and investment communities. The company's longevity might also indicate a resilient business model capable of adapting to evolving market conditions over several decades.
It's important to note that UEL operates as a subsidiary of Nerka Chemicals Private Limited. This organizational structure indicates that UEL's strategic direction and operational decisions are ultimately influenced by its parent company. The nature of the relationship between Nerka Chemicals and UEL, and the extent to which Nerka Chemicals provides resources or direction, are not detailed in the available information.
In summary, Uniphos Enterprises Limited functions as a multifaceted company operating within the chemical trading and investment sectors in India. Its long operational history and subsidiary status within a larger chemical entity provide context for understanding its position and activities within the Indian market. However, the specifics of its product range, investment portfolio, and the exact nature of its relationship with its parent company are not fully elaborated upon in the source material.
COMPANY FACTS - UNIENTER
Registered Address
Uniphos House, C. D. Marg, 11Th Roard, Madhu Park
Mumbai
MAHARASHTRA
IN
Tel: 912226468008
Website:https://www.uelonline.com/
Investor Relations:http://www.uelonline.com/investors.html
Company Details
Group: Capital Goods
Sector: Industrials
Industry: Trading Companies & Distributors
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
0IPO Date: 24/02/1994
MANAGEMENT - UNIENTER
Mr. Arun Ashar
Non-Executive Chairman of the Board
Mrs. Sandra Shroff
Non-Executive Vice Chairman of the Board
Mr. Bipin Chheda
Chief Financial Officer
Mr. K. Thacker
Compliance Officer, Company Secretary
Mr. Rajnikant Shroff
Managing Director
Mr. Jaidev Shroff
Non-Executive Director
Mr. Suresh Balasubramaniam
Additional Non-Executive Independent Director
Mr. Prasad Paranjape
Additional Non-Executive Independent Director
Mrs. Meena Ved
Additional Non-Executive Independent Director
Investor Questions Answered
Uniphos Enterprises Ltd (UNIENTER) Stock FAQs
Get answers to the most common questions about Uniphos Enterprises Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of Uniphos Enterprises Ltd (UNIENTER) is ₹95.11. Today, the stock has gained by ₹0.87 (0.92%), trading in a range of ₹90 to ₹96.97. The stock opened at ₹94 with a trading volume of 1,712 shares.
Uniphos Enterprises Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹799.78 crores, P/E ratio of 42.12, ROE of 0.77%, and ROCE of 0.06%. The dividend yield stands at 0.43%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Uniphos Enterprises Ltd (UNIENTER) is ₹168.5, while the 52-week low is ₹87.51. Currently trading at ₹95.11, the stock is 9.4% away from its 52-week low and 43.6% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Uniphos Enterprises Ltd stock at ₹95.11 depends on multiple factors. The stock is currently trading with a P/E ratio of 42.12 and P/B ratio of N/A. Today's performance shows a gain of 0.92%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Uniphos Enterprises Ltd offers a dividend yield of 0.43%, which means for every ₹100 invested at the current price of ₹95.11, you can expect to receive approximately ₹0.43 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Uniphos Enterprises Ltd's key financial metrics include: P/E Ratio: 42.12, P/B Ratio: N/A, ROE: 0.77%, ROCE: 0.06%, Dividend Yield: 0.43%, EPS: ₹2.73, Book Value: ₹394.22, Debt-to-Equity: 0.00, and Current Ratio: N/A. The company's market cap stands at ₹799.78 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Uniphos Enterprises Ltd stock opened at ₹94 and is currently trading at ₹95.11, showing a gain of ₹0.87 (0.92%). The intraday high is ₹96.97 and low is ₹90. The trading volume stands at 1,712 shares, indicating moderate market participation today.
Uniphos Enterprises Ltd has a Price-to-Earnings (P/E) ratio of 42.12, which means investors are willing to pay ₹42.12 for every ₹1 of earnings. With an EPS of ₹2.73, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
Uniphos Enterprises Ltd has a market capitalization of ₹799.78 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹95.11) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Uniphos Enterprises Ltd has a book value of ₹394.22 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹95.11, which is 75.9% below the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Uniphos Enterprises Ltd has a Return on Equity (ROE) of 0.77% and Return on Capital Employed (ROCE) of 0.06%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Uniphos Enterprises Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Uniphos Enterprises Ltd has a debt-to-equity ratio of 0.00, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Uniphos Enterprises Ltd has an Earnings Per Share (EPS) of ₹2.73, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹95.11 and P/E ratio of 42.12, investors are paying 42.12 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Uniphos Enterprises Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Uniphos Enterprises Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Uniphos Enterprises Ltd stock, consider: 1) Fundamental Analysis - Review P/E (42.12), ROE (0.77%), debt-to-equity (0.00), and growth rates. 2) Technical Analysis - Check 52-week range (₹87.51 - ₹168.50), moving averages, and chart patterns. 3) Valuation - Compare current price (₹95.11) with book value (₹394.22) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Uniphos Enterprises Ltd share is ₹2.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹95.11 is 4656x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Uniphos Enterprises Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹87.51 - ₹168.50). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.00 indicates leverage. 4) Liquidity Risk - Based on trading volume of 1,712 shares. 5) Valuation Risk - P/E of 42.12 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Uniphos Enterprises Ltd operates in the industry with key metrics: P/E ratio of 42.12, ROE of 0.77%, market cap of ₹799.78 crores, and dividend yield of 0.43%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.00), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Uniphos Enterprises Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹95.11, with a 52-week range of ₹87.51 to ₹168.50. Based on fundamentals like P/E (42.12), ROE (0.77%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Uniphos Enterprises Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹95.11. 2) Fundamental Deterioration - Declining ROE (currently 0.77%), increasing debt (D/E: 0.00), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Uniphos Enterprises Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.43%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu